Trading Halt
Released
Released
Announcement PDF
Market Announcement
6 October 2023
PharmAust Limited (ASX: PAA) – Trading Halt
Description
The securities of PharmAust Limited (‘PAA’) will be placed in trading halt at the request of PAA, pending it
releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the
earlier of the commencement of normal trading on Tuesday, 10 October 2023 or when the announcement is
released to the market.
Issued by
Scarlette de Lavaine
Adviser, Listings Compliance
6 October 2023
ASX Limited
Market Announcement 1/1
ASX Customer Service Centre 131 279 | asx.com.au
6 October 2023
Ms Barbara Lim
Australian Securities Exchange
Level 40, Central Park
152-158 St Georges Terrace
PERTH WA 6000
Dear Ms Lim,
TRADING HALT REQUEST
PharmAust Limited (ASX: PAA & PAAO) hereby makes application for a trading halt of its securities and
provides the following information in relation to Listing Rule 17.1:
•
The Company makes the request pending an announcement of results from the Phase 2 Canine
Trial;
•
The Company requests the securities remain in pre-open until the earlier of an announcement
or the commencement of trade on Tuesday 10 October 2023; and
•
The Company is not aware of any reason why the trading halt should not be granted; and
•
The Company is not aware of any other information necessary to inform the market about the
trading halt.
Yours sincerely,
Sam Wright
Director & Company Secretary
PharmAust Limited ABN 35 094 006 023. Suite 116, 1 Kyle Way, Claremont, Western Australia
Tel: 08 9202 6814 Fax: 08 9467 6111
www.pharmaust.com
Share your feedback
Discover